The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Soluble cytokine receptors are present in normal human urine.
Open accessAbstract
Affinity chromatography of crude human urinary proteins on either human rIL-6, human rIFN-gamma, or anti-IFN-gamma-R mAb yielded the two respective soluble receptors in significant quantities. A single sequence of 30 amino acid residues was obtained by NH2-terminal microsequencing of the protein peak purified in tandem by affinity chromatography on an IL-6 column and reversed-phase HPLC. This sequence was identical to the predicted NH2-terminal sequence of IL-6-R as previously reported. Analysis of the eluted proteins from both IFN-gamma and anti-IFN-gamma-R columns by inhibition of solid phase RIA, ELISA, SDS-PAGE, and Western blotting proved the existence of soluble IFN-gamma-R in normal urine. Our finding, together with the already known presence of urinary TNF binding proteins and a soluble IL-2-R both in plasma and in urine, indicates that release of soluble cytokine receptors into body fluids is a general phenomenon that occurs under normal physiological conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gels
Oakley, B. R., Kirsch, D. R., & Morris, N. R. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90470-4 · Cited by 3,247
Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.
Rubin, L. A., Kurman, C. C., Fritz, M. E., Biddison, W. E., Boutin, B., Yarchoan, R., & Nelson, D. L. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.5.3172 · Cited by 1,145
Cloning and Expression of the Human Interleukin-6 (BSF-2/IFNβ 2) Receptor
Yamasaki, K., Taga, T., Hirata, Y., Yawata, H., Kawanishi, Y., Seed, B., Taniguchi, T., Hirano, T., & Kishimoto, T. (1988) · Science · doi:10.1126/science.3136546 · Cited by 1,060
A human inhibitor of tumor necrosis factor alpha.
Seckinger, P., Isaaz, S., & Dayer, J. M. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.4.1511 · Cited by 255
A tumor necrosis factor binding protein is present in human biological fluids
Peetre, C., Thysell, H., GRUBB, A. O., & Olsson, I. (1988) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1988.tb00220.x · Cited by 115
The human interferon-gamma receptor. Purification, characterization, and preparation of antibodies.
Novick, D., Orchansky, P. L., Revel, M., & Rubinstein, M. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47439-x · Cited by 82
Self-citationNovick, D., Eshhar, Z., Fischer, D. G., Friedlander, J., & Rubinstein, M. (1983) · The EMBO Journal · doi:10.1002/j.1460-2075.1983.tb01618.x · Cited by 64
Self-citation
Cited by
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Johnson, D. E., O'Keefe, R. A., & Grandis, J. R. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.8 · Cited by 3,110
ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.397 · Cited by 2,514
IL-6 as a keystone cytokine in health and disease
Hunter, C. A., & Jones, S. A. (2015) · Nature Immunology · doi:10.1038/ni.3153 · Cited by 2,511
Interleukin-1 and interleukin-1 antagonism
Dinarello, C. (1991) · Blood · doi:10.1182/blood.v77.8.1627.1627 · Cited by 2,304
Interleukin-6 in Biology and Medicine
Akira, S., Taga, T., & Kishimoto, T. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60532-5 · Cited by 1,389
Age-Associated Increased Interleukin-6 Gene Expression, Late-Life Diseases, and Frailty
Ershler, W. B., & Keller, E. T. (2000) · Annual Review of Medicine · doi:10.1146/annurev.med.51.1.245 · Cited by 1,282
Role of IL-6 and Its Soluble Receptor in Induction of Chemokines and Leukocyte Recruitment
Romano, M., Sironi, M., Toniatti, C., Polentarutti, N., Fruscella, P., Ghezzi, P., Faggioni, R., Luini, W., van Hinsbergh, V., Sozzani, S., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80334-9 · Cited by 1,112
Rose-John, S. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4989 · Cited by 1,040
“Interestingly, a soluble form of the IL-6R (sIL-6R) has been found in body fluids such as urine and blood [13] and it was shown that in humans, the sIL-6R could be generated by two different mechanisms, limited proteolysis of the membrane bound receptor by the metalloprotease ADAM17 [14] and by translation of a differ…”
BackgroundMolecular cloning and expression of a receptor for human tumor necrosis factor
Schall, T. J., Lewis, M., Koller, K. J., Lee, A., Rice, G. C., Wong, G. H. W., Gatanaga, T., Granger, G. A., Lentz, R., Raab, H., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90816-w · Cited by 964
Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis
Arend, W. P., & Dayer, J. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330302 · Cited by 949
McCoy, M. K., & Tansey, M. G. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-45 · Cited by 847
Viral Subversion of the Immune System
Tortorella, D., Gewurz, B. E., Furman, M. H., Schust, D. J., & Ploegh, H. L. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.861 · Cited by 835
Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.
Tamura, T., Udagawa, N., Takahashi, N., Miyaura, C., Tanaka, S., Yamada, Y., Koishihara, Y., Ohsugi, Y., Kumaki, K., & Taga, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11924 · Cited by 825
IL-18: A TH1 -inducing, proinflammatory cytokine and new member of the IL-1 family
Dinarello, C. A. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70518-x · Cited by 819
Interleukin-18 Binding Protein
Novick, D., Kim, S.-H., Fantuzzi, G., Reznikov, L. L., Dinarello, C. A., & Rubinstein, M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80013-8 · Cited by 779
Self-citationSoluble receptors for cytokines and growth factors: generation and biological function
Rose-John, S., & Heinrich, P. C. (1994) · Biochemical Journal · doi:10.1042/bj3000281 · Cited by 775
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
Jones, S. A., Scheller, J., & Rose-John, S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57158 · Cited by 683
The human interferon $alpha;/$beta; receptor: Characterization and molecular cloning
NOVICK, D. (1994) · Cell · doi:10.1016/0092-8674(94)90154-6 · Cited by 667
Self-citationPigott, R., Dillon, L. P., Hemingway, I. H., & Gearing, A. J. H. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91234-h · Cited by 649
The soluble interleukin 6 receptor: mechanisms of production and implications in disease
JONES, S. A., HORIUCHI, S., TOPLEY, N., YAMAMOTO, N., & FULLER, G. M. (2001) · The FASEB Journal · doi:10.1096/fj.99-1003rev · Cited by 623
Interleukin-6 and its receptors: a highly regulated and dynamic system
Wolf, J., Rose-John, S., & Garbers, C. (2014) · Cytokine · doi:10.1016/j.cyto.2014.05.024 · Cited by 618
Goodwin, R. (1990) · Cell · doi:10.1016/0092-8674(90)90342-c · Cited by 599
Tavernier, J., Devos, R., Cornelis, S., Tuypens, T., Van der Heyden, J., Fiers, W., & Plaetinck, G. (1991) · Cell · doi:10.1016/0092-8674(91)90040-6 · Cited by 575
Engelmann, H., Novick, D., & Wallach, D. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40049-5 · Cited by 549
Self-citationCytokines, chemokines and growth factors in endometrium related to implantation
Dimitriadis, E., White, C. A., Jones, R. L., & Salamonsen, L. A. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi023 · Cited by 548
Kotake, S., Sato, K., Kim, K. J., Takahashi, N., Udagawa, N., Nakamura, I., Yamaguchi, A., Kishimoto, T., Suda, T., & Kashiwazaki, S. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110113 · Cited by 545
Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An Update
Su, H., Lei, C.-T., & Zhang, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00405 · Cited by 524
The soluble interleukin‐6 receptor is generated by shedding
Mülberg, J., Schooltink, H., Stoyan, T., Günther, M., Graeve, L., Buse, G., Mackiewicz, A., Heinrich, P. C., & Rose‐John, S. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230226 · Cited by 506
Interleukin‐1β, Interleukin‐18, and the Interleukin‐1β Converting Enzymea
DINARELLO, C. A. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb08307.x · Cited by 498
Effects of cytokines on the liver
Andus, T., Bauer, J., & Gerok, W. (1991) · Hepatology · doi:10.1002/hep.1840130226 · Cited by 419
Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo
Mohamed-Ali, V., Goodrick, S., Bulmer, K., Holly, J. M. P., Yudkin, J. S., & Coppack, S. W. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.6.e971 · Cited by 398
Dinarello, C. A. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/163.6.1177 · Cited by 397
Cytokines as Endogenous Pyrogens
Dinarello, C. A. (1999) · The Journal of Infectious Diseases · doi:10.1086/513856 · Cited by 387
Overview of interleukin-18: more than an interferon-γ inducing factor
Dinarello, C. A., Novick, D., Puren, A. J., Fantuzzi, G., Shapiro, L., Mühl, H., Yoon, D.-Y., Reznikov, L. L., Kim, S.-H., & Rubinstein, M. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.63.6.658 · Cited by 374
Self-citationInterleukin‐6: Structure‐function relationships
Simpson, R. J., Hammacher, A., Smith, D. K., Matthews, J. M., & Ward, L. D. (1997) · Protein Science · doi:10.1002/pro.5560060501 · Cited by 371
Interleukin‐6 and its receptor in cancer: Implications for Translational Therapeutics
Hong, D. S., Angelo, L. S., & Kurzrock, R. (2007) · Cancer · doi:10.1002/cncr.22999 · Cited by 370
“A soluble form of the IL-6Ra chain was purified first from human urine.(12) Soluble IL-6Ra (sIL-6Ra) binds to IL6 and forms a circulating complex.”
BackgroundDinarello, C. A. (1999) · Methods · doi:10.1006/meth.1999.0837 · Cited by 369
Interleukin-6 expression and regulation in astrocytes
Van Wagoner, N. J., & Benveniste, E. N. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00187-3 · Cited by 363
Interleukin-6, a mental cytokine
Spooren, A., Kolmus, K., Laureys, G., Clinckers, R., De Keyser, J., Haegeman, G., & Gerlo, S. (2011) · Brain Research Reviews · doi:10.1016/j.brainresrev.2011.01.002 · Cited by 352
Released Form of CNTF Receptor α Component as a Soluble Mediator of CNTF Responses
Davis, S., Aldrich, T. H., Ip, N. Y., Stahl, N., Scherer, S., Farruggella, T., DiStefano, P. S., Curtis, R., Panayotatos, N., Gascan, H., et al. (1993) · Science · doi:10.1126/science.7681218 · Cited by 350
Cope, A. P., Gibbons, D., Brennan, F. M., Feldmann, M., Aderka, D., Doherty, M., Jones, A. C., Engelmann, H., Wallach, D., & Maini, R. N. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780351008 · Cited by 337
Self-citationKern, L., Mittenbühler, M., Vesting, A., Ostermann, A., Wunderlich, C., & Wunderlich, F. (2018) · Cancers · doi:10.3390/cancers11010024 · Cited by 331
“Besides the membrane-bound IL-6Rα, a soluble form (sIL-6Rα), which induces IL-6 trans-signaling, has been described [107].”
BackgroundNophar, Y., Kemper, O., Brakebusch, C., Englemann, H., Zwang, R., Aderka, D., Holtmann, H., & Wallach, D. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07526.x · Cited by 331
Self-citationBalcewicz-Sablinska, M. K., Keane, J., Kornfeld, H., & Remold, H. G. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2636 · Cited by 318
Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor
Lust, J. A., Donovan, K. A., Kline, M. P., Greipp, P. R., Kyle, R. A., & Maihle, N. J. (1992) · Cytokine · doi:10.1016/1043-4666(92)90043-q · Cited by 316
IL-6/JAK/STAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment
Manore, S. G., Doheny, D. L., Wong, G. L., & Lo, H.-W. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.866014 · Cited by 307
Encoding of a Homolog of the IFN-γ Receptor by Myxoma Virus
Upton, C., Mossman, K., & McFadden, G. (1992) · Science · doi:10.1126/science.1455233 · Cited by 304
Alcamí, A., & Smith, G. L. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.4633-4639.1995 · Cited by 301
Three different mRNAs encoding human granulocyte colony-stimulating factor receptor.
Fukunaga, R., Seto, Y., Mizushima, S., & Nagata, S. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.22.8702 · Cited by 288
Interleukin‐18 and Host Defense against Infection
Dinarello, C. A., & Fantuzzi, G. (2003) · The Journal of Infectious Diseases · doi:10.1086/374751 · Cited by 287
Cassatella, M. A., Meda, L., Gasperini, S., Calzetti, F., & Bonora, S. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.5.1695 · Cited by 284
Peters, M., Jacobs, S., Ehlers, M., Vollmer, P., Müllberg, J., Wolf, E., Brem, G., Meyer zum Büschenfelde, K. H., & Rose-John, S. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1399 · Cited by 276
Sindhu, S., Thomas, R., Shihab, P., Sriraman, D., Behbehani, K., & Ahmad, R. (2015) · PLOS ONE · doi:10.1371/journal.pone.0133494 · Cited by 265
Jones, S. A., & Rose-John, S. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00319-1 · Cited by 255
gp130 at the nexus of inflammation, autoimmunity, and cancer
Silver, J. S., & Hunter, C. A. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0410217 · Cited by 254
Brenn, D., Richter, F., & Schaible, H. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22282 · Cited by 252
Gupta, S., Hirota, M., Waugh, S. M., Murakami, I., Suzuki, T., Muraguchi, M., Shibamori, M., Ishikawa, Y., Jarvis, T. C., Carter, J. D., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.532580 · Cited by 151
“In addition to the membrane-bound IL-6R , a soluble form of IL-6R (sIL-6R ) is present in high concentration in blood and other body fluids (6, 7) and has an affinity for IL-6 that is similar to the membrane-bound receptor.”
BackgroundProteolytic Origin of the Soluble Human IL-6R In Vivo and a Decisive Role of N-Glycosylation
Riethmueller, S., Somasundaram, P., Ehlers, J. C., Hung, C.-W., Flynn, C. M., Lokau, J., Agthe, M., Düsterhöft, S., Zhu, Y., Grötzinger, J., et al. (2017) · PLOS Biology · doi:10.1371/journal.pbio.2000080 · Cited by 135
Estrogen augments glucose transporter and IGF1 expression in primate cerebral cortex
CHENG, C. M., COHEN, M., WANG, J., & BONDY, C. A. (2001) · The FASEB Journal · doi:10.1096/fj.00-0398com · Cited by 115
The hormetic and hermetic role of IL-6
Forcina, L., Franceschi, C., & Musarò, A. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101697 · Cited by 85
Interleukin-6 expression after renal transplantation
Waiser, J., Budde, K., Katalinic, A., Kuerzdorfer, M., Riess, R., & Neumayer, H. H. (1997) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/12.4.753 · Cited by 79
An Antiviral Soluble Form of the LDL Receptor Induced by Interferon
Fischer, D. G., Tal, N., Novick, D., Barak, S., & Rubinstein, M. (1993) · Science · doi:10.1126/science.8211145 · Cited by 63
Self-citation
Metadata
- Authors
- Novick, D., Engelmann, H., Wallach, D., & Rubinstein, M.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1989-10-01
- Volume
- 170
- Issue
- 4
- Pages
- 1409-1414
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2120486924
- Cited by
- 434
- References
- 9
- FWCI
- 17.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.